H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001144204-19-024246 Size: 5 MB 网页链接
$Cytosorbents(CTSO)$ 美东时间 2019-05-07 盘后 披露财报,预期EPS -0.18 网页链接
$Cytosorbents(CTSO)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-22 AccNo: 0001144204-19-020456 Size: 2 MB 网页链接
$Cytosorbents(CTSO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-04-22 AccNo: 0001144204-19-020458 Size: 1 MB 网页链接
$Cytosorbents(CTSO)$ PRE 14A - Other preliminary proxy statements Filed: 2019-04-05 AccNo: 0001144204-19-018460 Size: 3 MB 网页链接
$Cytosorbents(CTSO)$ CT ORDER - Confidential treatment order Filed: 2019-03-19 AccNo: 9999999997-19-001434 Size: 107 KB 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-03-13 AccNo: 0001144204-19-013747 Size: 126 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-07 AccNo: 0001144204-19-012774 Size: 11 MB 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-03-07 AccNo: 0001144204-19-012616 Size: 22 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Cytosorbents(CTSO)$ 美东时间 2019-03-07 盘后 披露财报,预期EPS -0.13 网页链接